Twitter/X et Bluesky
10/07/2020
Hugues Caly, Hamed Rabiei, Perrine Coste-Mazeau, Sebastien Hantz, Sophie Alain, Jean-Luc Eyraud, Thierry Chianea, Catherine Caly, et al. (2020). Pregnancy data enable identification of relevant biomarkers and a partial prognosis of autism at birth. openRxiv.
Lien vers la source citée10/07/2020
Jon E. Grant, Samuel R. Chamberlain (2021). Autistic traits in young adults who gamble. CNS Spectrums, 26(6), 637-642. Cambridge University Press (CUP).
Lien vers la source citée10/07/2020
3 réponses intégrées de Michelle Dawson
10/07/2020 03:33
Note: see also https://t.co/f6oZ4GOQx9 and in case anyone's forgotten, balovaptan for autism received the FDA's "Breakthrough Therapy Designation" in 2018 (look it up)
Voir la réponse sur Twitter/X17/07/2020 01:38
Update: today, Hoffman-La Roche changed the status of this study from "terminated" to "completed" (?) https://t.co/2z1f4NTr3T
Voir la réponse sur Twitter/X25/07/2020 02:54
Another update: today, Hoffman-La Roche changed the status of this study from "completed" back to "terminated" https://t.co/GNhLHe8Rco
Voir la réponse sur Twitter/XHoffmann-La Roche (2018). A Study of Balovaptan in Adults With Autism Spectrum Disorder With a 2-Year Open-Label Extension. ClinicalTrials.gov. Hoffmann-La Roche.
Lien vers la source citée10/07/2020
Irene García-Domínguez, Irene Suárez-Pereira, Marti Santiago, Eva M. Pérez-Villegas, Lidia Bravo, Carolina López-Martín, María Angustias Roca-Ceballos, Juan García-Revilla, et al. (2021). Selective deletion of Caspase-3 gene in the dopaminergic system exhibits autistic-like behaviour. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 104, 110030. Elsevier BV.
Lien vers la source citée09/07/2020
Rutgers, The State University of New Jersey (2020). ASD (Autism Spectrum Disorder) Telehealth for Distress Related to COVID-19. ClinicalTrials.gov. Rutgers, The State University of New Jersey.
Lien vers la source citée09/07/2020
Danielle A. Baribeau, Simone Vigod, Eleanor Pullenayegum, Connor M. Kerns, Pat Mirenda, Isabel M. Smith, Tracy Vaillancourt, Joanne Volden, et al. (2021). Co-occurring trajectories of anxiety and insistence on sameness behaviour in autism spectrum disorder. The British Journal of Psychiatry, 218(1), 20-27. Royal College of Psychiatrists.
Lien vers la source citée08/07/2020
1 réponse intégrée de Michelle Dawson
08/07/2020 23:33
Note: there are COIs, including "Drs. Wink and Erickson are inventors on a patent describing use of ketamine in autism"
Voir la réponse sur Twitter/XLogan K. Wink, Debra L. Reisinger, Paul Horn, Rebecca C. Shaffer, Kaela O’Brien, Lauren Schmitt, Kelli R. Dominick, Ernest V. Pedapati, et al. (2021). Brief Report: Intranasal Ketamine in Adolescents and Young Adults with Autism Spectrum Disorder—Initial Results of a Randomized, Controlled, Crossover, Pilot Study. Journal of Autism and Developmental Disorders, 51(4), 1392-1399. Springer Science and Business Media LLC.
Lien vers la source citée08/07/2020
Lisa Toffoli, Gaia Scerif, Margaret (Maggie) J. Snowling, Anthony Norcia, Catherine Manning (2020). Global motion evoked potentials in autistic and dyslexic children: a cross-syndrome approach. Center for Open Science.
Lien vers la source citée08/07/2020
08/07/2020
Aucun lien cité n’a été identifié pour ce billet.